Immunochemotherapy

2

Review clinical trials related to Immunochemotherapy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

Efficacy evaluation of camrelizumab combined with chemotherapy for adjuvant treatment of patients with pathologically confirmed lymph node-positive cervical cancer after staging surgery.

Participants needed: 59
Trial details
Phase: Phase 2Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Women's Hospital School Of Medicine Zhejiang UniversityUpdated: Dec 18, 2025Locations: 1
Eligibility criteria

Patients with cervical cancer staged FIGO2018 IIIC1p or IIIC2p after radical sur... [+2]

Positive parametrium or surgical margin; [+4]

Status: Not yet recruiting

Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma

Previously untreated patients with follicular lymphoma are treated with the ZGCVP regimen (zanubrutinib, obinutuzumab, cyclophosphamide, vindesine, prednisolone) for 6 cycles.

Participants needed: 58
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Zhejiang Cancer HospitalUpdated: Apr 15, 2025Locations: 1
Eligibility criteria

Participate in the clinical study voluntarily, fully understand and be informed... [+12]

Central nervous system involvement secondary to lymphoma. [+11]